Description of the medicine: Mesna (Mesna)
MESNA (Mesna) *.
2-mercaptoethanesulfonic acid sodium salt.
Synonyms: Mistabron, Mistabron, Mucofluid, Mucolene, etc.
In action, the drug is close to acetylcysteine. Due to the presence of the sulfhydryl group, it is able to break the disulfide bonds of mucopoli of sputum saccharides and reduce its viscosity.
The drug is easily absorbed from the respiratory tract. It is rapidly excreted unchanged from the body.
It is used in the form of inhalations or intrabronchial infusions in chronic bronchitis, emphysema, lung atelectasis, after surgical interventions on the lungs, etc.
For inhalation, 0.6 - 1, 2 g of the drug (1 - 2 ampoules of 3 ml of a 20% solution) are used without dilution or 1: 1 dilution in distilled water or in an isotonic solution of sodium chloride. Inhalations are carried out 2 to 3 times a day. The course of treatment is 2 to 24 days. For intratracheal infusion, it is used in the same dose and in the same dilution. Enter every hour until liquefaction and secretion.
In case of inflammation of the maxillary (maxillary) sinus, 2–3 ml of the drug is administered after preliminary sinus washing (every 2–3 days if necessary).
Possible side effects and contraindications see Acetylcysteine.
Release form: 20% solution in ampoules of 3 ml (600 mg) in a package of 6 ampoules.